Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Keith Stockerl-Goldstein

9PUBLICATIONS

99CO-AUTHORS

Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHumoural immunology and immunochemistryHaematology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Mar 02, 2026

Efficacy and Safety of Belantamab Mafodotin with Bortezomib plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: The DREAMM-6 Arm B Trial.

Rakesh Popat, Bradley Augustson, Paul Cannell

|Mar 12, 2025

Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Oct 04, 2024

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.

Meagan A Jacoby, Eric D Duncavage, Ajay Khanna

|May 06, 2023

A Single Reference Interval for Interpreting Serum Free Light Chains across Patients with Varying Renal Function.

Vahid Azimi, Michael Slade, Mark Fiala

|Apr 17, 2023

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe

|Mar 09, 2022

Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch

Pageof 2

Frequent Collaborators

3 joint publications

Geoffrey L Uy

3 joint publications

Celia C Cubitt

3 joint publications

Pamela Wong

3 joint publications

Jennifer A Foltz

3 joint publications

Mark Schroeder

3 joint publications

John F DiPersio

2 joint publications

Melissa M Berrien-Elliott

2 joint publications

Nancy D Marin

2 joint publications

Jennifer Tran

2 joint publications

David A Russler-Germain

Frequent Collaborators

3 joint publications

Geoffrey L Uy

3 joint publications

Celia C Cubitt

3 joint publications

Pamela Wong

3 joint publications

Jennifer A Foltz

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on : Feb 14, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on : Mar 26, 2018

See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on : Feb 14, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on : Mar 26, 2018

See more related videos